The impact of the coronavirus 2019 disease (COVID-19) pandemic on children with medical complexity (CMC) has been substantial. Although severe COVID-19 illness is relatively rare among children and youth, many CMC are at a comparatively increased risk.1  Perhaps of even greater concern has been the indirect impacts of the pandemic on the well-being of CMCs, including barriers to accessing care, social supports, and education, as well as the consequences of caregiver illness and caregiver stress on the health of these children.2,3  Nevertheless, there have been some reports that at least one aspect of CMC health may have improved over the course of the pandemic, their risk of acute care hospitalization. Data from early in the pandemic suggested dramatic declines in hospitalization risk among children,4  including those that are healthy and those with chronic conditions. A large, more recent study from the UK reported substantial declines in hospitalizations for children, including those with preexisting comorbidities, with the most significant reductions in respiratory conditions, such as influenza and bronchiolitis.5  To date there have been few reports that specifically described changes in acute care utilization by CMC during the pandemic. Understanding the changes in this population are essential since they are such frequent users of inpatient services and are at substantially higher risk of poor outcomes during hospitalization.68 

The paper by Markham et al9  in this edition of Hospital Pediatrics provides some important insights into the patterns of acute care use among CMC during the pandemic. This multicenter cross-sectional study reviewed admission trends in 49 US children’s hospitals using the Pediatric Health Information System (PHIS) database. The authors used a commonly used algorithm for ascertaining CMC with health administrative data, Feudtner’s complex chronic conditions (CCCs)10  and compared utilization during the first year of the pandemic with that in the 3 years prior. The study reported that children with a CCC had a 19.5% decline in admissions during COVID-19, beginning right at the onset of the pandemic in March 2020, reaching a rapid nadir 1 month later, but still not returning to pre-COVID levels by March 2021. The decline in admissions was particularly notable for respiratory diagnoses, such as pneumonia and bronchiolitis (44.7% to 57.7% decline). Despite the marked drop in admissions, other indicators of hospitalization disease burden for CMC, including length of stay and ICU days, were not substantially different.

Why did CMC require fewer hospitalizations during the first year of the pandemic? The authors offer 2 plausible explanations. Pandemic measures to control the spread of COVID-19, such as social distancing, masking, and school closures likely also limited the spread of other respiratory viruses. Declines in activity of influenza and respiratory syncytial virus (RSV) have been well described during the pandemic.11  Such viruses are known to lead to substantial morbidity and mortality among CMC. For example, RSV has the highest mortality risk among CMC, including those with cardiac conditions, chronic lung disease, neurologic impairment, and genetic disorders.1215 

Another explanation could be that many families may have simply delayed or forgone care in hospitals during the first year of the pandemic. This phenomenon has been described by other researchers during the pandemic among the CMC population.16,17  Limitations inherent to the study design make it challenging to untangle these and other potential explanatory factors. Administrative data cannot determine whether an admission is related to changes in health behaviors, decreased community supports, or an exacerbation of their underlying medical condition. Additionally, the PHIS database does not contain data on community hospital admissions, and some families may have received care in such hospitals that may be closer to their homes. It is also not known what the patterns of ambulatory care were among the CMC in the study, including access to telemedicine that may have provided support to families.

It is important to highlight that this study was conducted during the first year of the pandemic (until March 2021). A key question emerging from this work is whether the decreased admissions noted during the early phase of the pandemic continued in subsequent periods as public health measures varied over time. It is also uncertain whether the patterns observed will continue. While public health measures may have reduced the risk of other respiratory infections during the COVID-19 pandemic, there is concern that with relaxation of such measures, susceptible individuals may be at risk from substantial outbreaks in the future.11  It will be important to continue to track hospitalization metrics over time to better understand how these factors may affect CMC.

And what about lessons for future pandemics or even seasonal surges of endemic viral infections? While the full scope of restrictions that existed in the worst phases of the pandemic, such as school closures and social isolation, have caused harms to CMC and their families,18  there may be important benefits to continue to protect them with some measures at times when they are most vulnerable. Is some of the decline in admissions, particularly those admissions due to viral respiratory infections, preventable with some public health measures? If so, is there a role for the use of masking, social distancing, and/or hand-washing campaigns around vulnerable CMC during periods of high rates of community transmission of viral respiratory infections? Or perhaps can increased use of telemedicine protect them from acquiring infections in health care settings during periods of viral surges? All of these questions will likely require rigorous evaluative methods, such as cluster randomized trials to answer.

Markham et al have provided us with important preliminary data that suggests that hospitalization of CMC has declined substantially during the pandemic, a potential silver lining in the dark cloud of the pandemic. Future research is essential to better understand this observation to optimize CMC health and well-being.

COMPANION PAPER: A companion to this article can be found online at www.hosppeds.org/cgi/doi/10.1542/hpeds.2021-006334.

1.
Kompaniyets
L
,
Agathis
NT
,
Nelson
JM
et al
.
Underlying medical conditions associated with severe COVID-19 illness among children
.
JAMA Netw Open
.
2021
;
4
(
6
):
e2111182
2.
Beight
LJ
,
Helton
G
,
Avery
M
,
Dussel
V
,
Wolfe
J
.
Parent and adolescent perspectives on the impact of COVID on the care of seriously ill children
.
J Pain Symptom Manage
.
2022
;
63
(
1
):
52
60
3.
Cacioppo
M
,
Bouvier
S
,
Bailly
R
et al
;
ECHO Group
.
Emerging health challenges for children with physical disabilities and their parents during the COVID-19 pandemic: the ECHO French survey
.
Ann Phys Rehabil Med
.
2021
;
64
(
3
):
101429
4.
Gavish
R
,
Levinsky
Y
,
Dizitzer
Y
,
Bilavsky
E
,
Livni
G
,
Pirogovsky
A
et al
.
The COVID-19 pandemic dramatically reduced admissions of children with and without chronic conditions to general paediatric wards
.
Acta Paediatrica
.
2021
;
110
(
7
):
2212
2217
5.
Kadambari
S
,
Goldacre
R
,
Morris
E
,
Goldacre
MJ
,
Pollard
AJ
.
Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study
.
BMJ
.
2022
;
376
:
e067519
6.
Cohen
E
,
Berry
JG
,
Camacho
X
,
Anderson
G
,
Wodchis
W
,
Guttmann
A
.
Patterns and costs of health care use of children with medical complexity
.
Pediatrics
.
2012
;
130
(
6
):
e1463
e1470
7.
Neff
JM
,
Sharp
VL
,
Muldoon
J
,
Graham
J
,
Myers
K
.
Profile of medical charges for children by health status group and severity level in a Washington State Health Plan
.
Health Serv Res
.
2004
;
39
(
1
):
73
89
8.
Simon
TD
,
Berry
J
,
Feudtner
C
et al
.
Children with complex chronic conditions in inpatient hospital settings in the United States
.
Pediatrics
.
2010
;
126
(
4
):
647
655
9.
Markham
JL
et al
.
Impact of COVID-19 on admissions and outcomes for children with complex chronic conditions
.
Hosp Pediatr
.
2021
;
12
(
4
):
e2021-006334
10.
Feudtner
C
,
Feinstein
JA
,
Zhong
W
,
Hall
M
,
Dai
D
.
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation
.
BMC Pediatr
.
2014
;
14
:
199
11.
Baker
RE
,
Park
SW
,
Yang
W
,
Vecchi
GA
,
Metcalf
CJE
,
Grenfell
BT
.
The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections
.
Proc Natl Acad Sci USA
.
2020
;
117
(
48
):
30547
30553
12.
Tam
J
,
Papenburg
J
,
Fanella
S
et al
.
Pediatric investigators collaborative network on infections in Canada study of respiratory syncytial virus-associated deaths in pediatric patients in Canada, 2003–2013
.
Clin Infect Dis
.
2019
;
68
(
1
):
113
119
13.
Scheltema
NM
,
Gentile
A
,
Lucion
F
et al
;
PERCH Study Group
.
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
.
Lancet Glob Health
.
2017
;
5
(
10
):
e984
e991
14.
Thorburn
K
.
Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection
.
Arch Dis Child
.
2009
;
94
(
2
):
99
103
15.
Lee
YI
,
Peng
CC
,
Chiu
NC
,
Huang
DT
,
Huang
FY
,
Chi
H
.
Risk factors associated with death in patients with severe respiratory syncytial virus infection
.
J Microbiol Immunol Infect
.
2016
;
49
(
5
):
737
742
16.
Diskin
C
,
Orkin
J
,
Agarwal
T
,
Parmar
A
,
Friedman
JN
.
The secondary consequences of the COVID-19 pandemic in hospital pediatrics
.
Hosp Pediatr
.
2021
;
11
(
2
):
208
212
17.
Ding
YY
,
Ramakrishna
S
,
Long
AH
et al
.
Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic
.
Pediatr Blood Cancer
.
2020
;
67
(
9
):
e28427
18.
Wong
CA
,
Ming
D
,
Maslow
G
,
Gifford
EJ
.
Mitigating the impacts of the COVID-19 pandemic response on at-risk children
.
Pediatrics
.
2020
;
146
(
1
):
e20200973